Saturday 21 April 2018

Julphar, FT plan major biotech forum in Dubai

Dubai, November 21, 2013

Julphar (Gulf Pharmaceutical Industries), a leading pharmaceutical company based in the UAE, will hold a strategic biotechnology forum in conjunction with the Financial Times next month.

The one-day forum will be hedl on December 9 in Dubai with the aim of laying down foundations for a world-class biotechnology industry in the Mena region.  

The forum will discuss the vital importance of biotechnology for the region as well as the emerging opportunities and challenges.  It will bring together industry experts, investors, policy makers and regulators from across the region and internationally to debate in a series of forums the financial and regulatory factors necessary for the success of this nascent industry, said a statement.

Commenting on the event, Dr Ayman Sahli, said: "This is a highly strategic forum that has the potential to transform the pharmaceutical industry in the region. The renowned experts who will convene in the UAE will tackle all the prerequisites for establishing an advanced biotechnology industry that will help local countries provide better healthcare services to their citizens”.

“Biotechnology is a strategic pharmaceutical domain that Julphar has already tapped into by establishing a state-of-the-art biotechnology plant to produce insulin locally, making of the UAE the first and only country in the region that produces the raw material used for making insulin. Fulfilling our commitment to the regional community, Julphar is determined to lead the industry on the biotechnology front”, added Dr Sahli.

Financial Times Live, the global conferences and events arm of the Financial Times newspaper, co-organiser of the forum, has long established itself as a global leader in gathering high calibre public and private sector decision-makers, visionaries and strategists from the world’s most important economies and industries for a wide range of interactive, agenda-setting conferences and events.  

Andrew Jack, pharmaceuticals correspondent of Financial Times and chair of the forum, said: “The forthcoming biotechnology forum is particularly relevant to this part of the world where local governments are investing hugely to meet the growing demand on quality healthcare”. - TradeArabia News Service

Tags: forum | biotechnology | Julphar | FT |

calendarCalendar of Events